Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

NovoCure Limited (NVCR) Institutional Ownership & Insider Trading

214 institutions reported holding NovoCure Limited shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 25 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NVCRNovoCure LimitedFollow NVCR — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

214 institutions held 88.8% of the shares. Across filers that reported both quarters, shares held changed +4.6%.

Increased+89New+25Decreased-58Closed-29

Largest moves, shares (millions)

Empowered Funds+1.2MAQR Capital Management+0.8MJPMorgan Chase+0.7MSG Americas Securities-1.2MT. Rowe Price Investment…-0.9MSchroder Investment…-0.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.6Sep 24-1.6Dec 24+3.2Mar 25-0.7Jun 25-2.4Sep 25+4.4Dec 25+2.6Mar 26+4.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26214103+4.6%89255829
Mar 2622199+3.1%75277243
Dec 2523495+4.8%91365836
Sep 2524292-2.6%77387437
Jun 2524294-0.7%79406521
Mar 2522695+3.5%65326842
Dec 2423792-1.8%62417131
Sep 2422193-1.9%58187729

NovoCure Limited — questions

Who owns NovoCure Limited stock?
214 institutions reported NovoCure Limited shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (14.9%), BlackRock, Inc. (11.5%), Soleus Capital Management, L.P. (8.5%).
Are NovoCure Limited insiders buying or selling?
25 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from NovoCure Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.